Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. (trading symbol: NAOV) on October 29, 2021. The report details a corporate governance action taken by the Board of Directors on the same date. Note: The request metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report regarding a change in bylaws and does not provide a clear value for any financial metric.
Material Changes
The material change reported is an amendment to the Company's Amended and Restated Bylaws, specifically Article I, Section 1.4. The Board approved lowering the quorum requirement for stockholder meetings from a majority of voting power to one-third of voting power. This change allows meetings to proceed with fewer shareholders present in person or by proxy.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are discussed beyond the standard legal reference to the amendment text. There are no unusual items reported in this document.
Key Facts for Investor Verification
- Verify the exact date the bylaw amendment became effective (October 29, 2021).
- Confirm the new quorum threshold is one-third of voting power, down from a majority.
- Review the attached Exhibit 3.1 for the full legal text of the amendment.
- Check subsequent filings to see if this change impacts upcoming stockholder meeting outcomes.